Search
LY-518674
go.drugbank.com/drugs/DB12988InvestigationalLY518674 has been used in trials studying the treatment of Metabolic Syndrome X.
Henatinib
go.drugbank.com/drugs/DB13019InvestigationalHenatinib has been used in trials studying the treatment of Advanced Solid Cancer.
IPI-493
go.drugbank.com/drugs/DB13023InvestigationalIPI-493 has been used in trials studying the treatment of Advanced Malignancies.
Tirilazad
go.drugbank.com/drugs/DB13050InvestigationalTirilazad has been used in trials studying the treatment of Spinal Cord Injury.
CEP-37440
go.drugbank.com/drugs/DB13060InvestigationalCEP-37440 has been used in trials studying the treatment of Solid Tumors.
LY-2811376
go.drugbank.com/drugs/DB13065InvestigationalLY2811376 has been used in trials studying the basic science of Alzheimer's Disease.
AZD-0424
go.drugbank.com/drugs/DB13088InvestigationalAZD0424 has been used in trials studying the treatment of Advanced Solid Tumours.
TAK-593
go.drugbank.com/drugs/DB13093InvestigationalTAK-593 has been used in trials studying the treatment of Solid Tumors.
JQ1
go.drugbank.com/drugs/DB17021ExperimentalFirst-in-class potent and selective inhibitor of the BRD4 signaling pathway.[A252967]
Suratadenoturev
go.drugbank.com/drugs/DB18672InvestigationalSuratadenoturev is a gene-modified oncolytic adenovirus expressing the telomerase reverse transcriptase gene.
Synonyms: A replication-competent adenovirus type 5 in which the E1A and E1B genes are under the control of a human telomerase reverse transcriptase (hTERT) and IRES, respectively., A recombinant replication-competent adenovirus type 5 (Ad-5) in which the E1 gene, including its normal transcriptional regulatory element, has been deleted and replaced by an expression cassette containing